Implementing MASLD Screening in Primary Care for Adults with Type 2 Diabetes: A Quality Improvement Initiative.
OBJECTIVE Metabolic dysfunction-associated steatotic liver disease (MASLD) affects over two-thirds of adults with type 2 diabetes (T2D), yet advanced fibrosis often remains undiagnosed. This quality improvement (QI) project implemented a standardized screening pathway to identify patients at risk for advanced fibrosis...